The Cyclophosphamide for Injection, cataloged under National Stock Number 6505-00-767-3578, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Erbamont Inc Adria Laboratories Div. Government technical data includes 10 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-00-767-3578 |
| Primary Part Number | NDC00013-5616-93 |
| Item Name | Cyclophosphamide for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Erbamont Inc Adria Laboratories Div |
| Status | ACTIVE |
| Therapeutic Equivalent | NEOSAR BY ADRIA LABS.,INC.; CYTOXAN BY BRISTOL LABS.,INC. |
| Primary Container Content Quantity | 200.000 MILLIGRAMS OF ACTIVE INGREDIENT |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Protective Storage Feature | ANTINEOPLASTIC DRUG |
| Warning and Caution Statements | CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE |
| Active Medicament Medicinal Strength | 200.000 MILLIGRAMS CYCLOPHOSPHAMIDE, ANHYDROUS ACTIVE INGREDIENT |
| Total Primary Container Quantity | 12 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00087-0501-01 | Mead Johnson & Company, Llc (USA) |
| NDC00013-5616-93 PRIMARY | Erbamont Inc Adria Laboratories Div (USA) |
| Reference | Meaning |
|---|---|
| NEOSAR | 5/1 Secondary reference Erbamont Inc Adria Laboratories Div |
NSN 6505-00-767-3578 is a Cyclophosphamide for Injection, manufactured by Erbamont Inc Adria Laboratories Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-767-3578 has 2 manufacturer part numbers on file: NDC00087-0501-01 (Mead Johnson & Company, Llc), NDC00013-5616-93 (Erbamont Inc Adria Laboratories Div).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-158-7889. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00013-5616-93: Therapeutic Equivalent: NEOSAR BY ADRIA LABS.,INC.; CYTOXAN BY BRISTOL LABS.,INC.; Primary Container Content Quantity: 200.000 MILLIGRAMS OF ACTIVE INGREDIENT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: STERILE. 10 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.